Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Cost-effectiveness analysis

Clinical and economic outcomes of adding [¹⁸F]FES PET/CT in estrogen receptor status identification in metastatic and recurrent breast cancer in the US

Regina Munter-Young, Adolfo Fuentes-Alburo, Nicholas DiGregorio, Kurt Neeser, Dmitry Gultyaev

published 14 May 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Cost-effectiveness of avelumab first-line maintenance therapy for adult patients with locally advanced or metastatic urothelial carcinoma in France

Fanny Porte, Anna Granghaud, Jane Chang, Mairead Kearney, Aya Morel, Ingrid Plessala, Hélène Cawston, Julie Roiz, Ying Xiao, Marie-Noelle Solbes, Prisca Lambert, Alain Ravaud, Yohann Loriot, Antoine Thiery-Vuillemin, Pierre Lévy

published 10 May 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Cost-effectiveness of left atrial appendage occlusion during cardiac surgery in France: An economic evaluation based on the LAAOS III study

Manon Benmalek, Martin Connock, Léa Savio, Jean-François Obadia, Xavier Armoiry

published 09 May 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Cost-effectiveness and cost-utility analyses of three different gargles in the treatment of chronic periodontitis

Xin Chen, Wenzhi Niu, Guangyu Hu, Changfeng Chen

published 08 May 2024

Loading metrics information...

Metrics unavailable. Please check back later.

The efficacy and safety of MARS-PD: Meridian activation remedy system for Parkinson’s disease—A single-center, assessor and statistician-blinded, parallel-group randomized, controlled trial protocol

Miso S. Park, SangSoo Park, Jie-Yoon Kang, In Chul Jung, HoRyong Yoo

published 06 May 2024

Loading metrics information...

Metrics unavailable. Please check back later.

A model-based cost-utility analysis of an automated notification system for deteriorating patients on general wards

Emily Holmes, Huw Lloyd Williams, Dyfrig Hughes, Elke Naujokat, Bernd Duller, Christian P. Subbe

published 02 May 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer

Tarun Mehra, Judith E. Lupatsch, Thibaud Kössler, Konstantin Dedes, Alexander Reinhard Siebenhüner, Roger von Moos, Andreas Wicki, Matthias E. Schwenkglenks

published 04 Apr 2024

Loading metrics information...

Metrics unavailable. Please check back later.

An economic evaluation of chronic obstructive pulmonary disease clinical pathway in Saskatchewan, Canada: Data-driven techniques to identify cost-effectiveness among patient subgroups

John Paul Kuwornu, Fernando Maldonado, Gary Groot, Elizabeth J. Cooper, Erika Penz, Leland Sommer, Amy Reid, Darcy D. Marciniuk

published 01 Apr 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Effectiveness and cost-effectiveness of a collaborative deprescribing intervention of proton-pump-inhibitors on community-dwelling older adults: Protocol for the C-SENIoR, a pragmatic non-randomized controlled trial

Sónia Romano, Luis Monteiro, José Pedro Guerreiro, João Braga Simões, António Teixeira Rodrigues, Nuno Lunet, Julian Perelman

published 26 Mar 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Cost-utility analysis of atezolizumab combined with bevacizumab for unresectable hepatocellular carcinoma in Thailand

Supachaya Sriphoosanaphan, Witthawat Pantumongkol, Wantanee Kulpeng, Chanchai Charonpongsuntorn, Tawesak Tanwandee, Wattana Sukeepaisarnjaroen, Abhasnee Sobhonslidsuk, Pisit Tangkijvanich

published 21 Mar 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Cost-effectiveness of one-year adjuvant trastuzumab therapy in treatment for early-stage breast cancer patients with HER2+ in Vietnam

Anh Quynh Nguyen, Oanh Thi Mai Tran, Phuong Khanh Nguyen, Ha Thu Nguyen

published 15 Mar 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Cost-effectiveness of screening for chronic kidney disease using a cumulative eGFR-based statistic

Reyhaneh Zafarnejad, Qiushi Chen, Paul M. Griffin

published 13 Mar 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Cost-effectiveness analysis of dapagliflozin for people with chronic kidney disease in Malaysia

Soo Kun Lim, Shaun Wen Huey Lee

published 06 Mar 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Advertisement

Create a weekly email alert for: Cost-effectiveness analysis

You can change these options by clicking profile then "Alerts and Notifications"